Rite Aid Corp (RAD)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rite Aid Corp (RAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012233
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rite Aid Corp (Rite Aid) is retail drugstore chain. The company sells prescription drugs and a wide range of other merchandise such as, over-the-counter (OTC) medications, personal care items, health and beauty aids, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchanise, photo processing and others. Rite Aid services portfolio include pharmacy-related solutions including fully integrated mail, specialty and compounding pharmacy services. The company also has a technology which helps its customer to fill or refill their prescription through internet under website www.riteaid.com. It operates through subsidiaries and retail drugstores in the US. Rite Aid is headquartered in Camp Hill, Pennsylvania, the US.

Rite Aid Corp (RAD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rite Aid Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Rite Aid Corp, Medical Devices Deals, 2011 to YTD 2017 10
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Rite Aid Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
TPG Capital Completes Acquisition Of Envision Pharma 12
Partnerships 14
RediClinic Enters into Joint Venture Agreement with MultiCare Health System 14
Debt Offering 15
Rite Aid Raises USD1.8 Billion in Private Placement of 6.125% Notes Due 2023 15
Rite Aid Completes Private Placement Of Notes Due 2021 For US$810 Million 16
Acquisition 17
Envision Pharma Acquires MedTrak 17
Rite Aid Acquires RediClinic, Operator Of Healthcare Clinics 18
Rite Aid Acquires Health Dialog Services From British United Provident Association 19
Envision Pharma Acquires ProScribe 20
Envision Pharma Acquires Laker Software 21
Rite Aid Acquires Kings Pharmacy East 22
Jean Coutu Completes Sale Of Minority Stake In Rite Aid For US$160 Million 23
MedTrak Services Acquires Beyond Rx From Pharmacy First 24
Rite Aid Corp – Key Competitors 25
Rite Aid Corp – Key Employees 26
Rite Aid Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Sep 28, 2017: Rite Aid Reports Fiscal 2018 Second Quarter Results 30
Sep 22, 2016: Rite Aid Reports Fiscal 2017 Second Quarter Results 31
Jun 06, 2016: Rite Aid Reports Fiscal 2017 First Quarter Results 32
Apr 07, 2016: Rite Aid Reports Fiscal 2016 Fourth Quarter and Full Year Results 33
Corporate Communications 36
Nov 17, 2017: Rite Aid Announces Senior Management Changes in Category Management 36
Nov 14, 2017: Rob Mullins Named Senior Vice President of Store Operations, Western Division 37
Nov 02, 2017: Rite Aid: Matt Schroeder Named Senior Vice President, Chief Accounting Officer and Treasurer 38
Sep 28, 2017: Kermit Crawford Joins Rite Aid as President and Chief Operating Officer of Rite Aid 39
Jan 23, 2017: Ken Black Named Senior Vice President of Human Resources and Chief Human Resources Officer 40
Feb 29, 2016: Rite Aid Announces Results of First-Ever Rite Aid Innovation Challenge 41
Feb 10, 2016: Rite Aid Foundation’s Big Hearts Give Challenge Awards Over $1.5 Million to KidCents Charities 42
Product News 43
Sep 27, 2016: Rite Aid Expands Naloxone Dispensing Program in Four Additional States 43
Aug 29, 2016: Rite Aid to Offer Naloxone Without Prescription in 13 States 44
Jul 20, 2017: Rite Aid Expands Naloxone Dispensing Program to Michigan and South Carolina 45
Jun 09, 2016: High Patient Satisfaction And Demand For IBgard Results In Expansion Of Availability To Rite Aid Stores Nationwide 46
Feb 15, 2017: Rite Aid Expands Naloxone Dispensing Program in Six Additional States 47
Other Significant Developments 48
Aug 17, 2016: Rite Aid and EnvisionRx Collaborate to Improve Medication Adherence and Health Outcomes Through New Rx90 Program 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Rite Aid Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rite Aid Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rite Aid Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Rite Aid Corp, Medical Devices Deals, 2011 to YTD 2017 10
Rite Aid Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
TPG Capital Completes Acquisition Of Envision Pharma 12
RediClinic Enters into Joint Venture Agreement with MultiCare Health System 14
Rite Aid Raises USD1.8 Billion in Private Placement of 6.125% Notes Due 2023 15
Rite Aid Completes Private Placement Of Notes Due 2021 For US$810 Million 16
Envision Pharma Acquires MedTrak 17
Rite Aid Acquires RediClinic, Operator Of Healthcare Clinics 18
Rite Aid Acquires Health Dialog Services From British United Provident Association 19
Envision Pharma Acquires ProScribe 20
Envision Pharma Acquires Laker Software 21
Rite Aid Acquires Kings Pharmacy East 22
Jean Coutu Completes Sale Of Minority Stake In Rite Aid For US$160 Million 23
MedTrak Services Acquires Beyond Rx From Pharmacy First 24
Rite Aid Corp, Key Competitors 25
Rite Aid Corp, Key Employees 26
Rite Aid Corp, Other Locations 28
Rite Aid Corp, Subsidiaries 28

★海外企業調査レポート[Rite Aid Corp (RAD)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Long Chen Paper Co., Ltd.:企業の戦略・SWOT・財務情報
    Long Chen Paper Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Long Chen Paper Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bare Escentuals Inc.:企業の戦略的SWOT分析
    Bare Escentuals Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Pack Corporation:企業の戦略・SWOT・財務分析
    The Pack Corporation - Strategy, SWOT and Corporate Finance Report Summary The Pack Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arab International Bank:企業の戦略・SWOT・財務分析
    Arab International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Guardant Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Gindalbie Metals Ltd:企業の戦略・SWOT・財務情報
    Gindalbie Metals Ltd - Strategy, SWOT and Corporate Finance Report Summary Gindalbie Metals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Salt River Project:企業の戦略・SWOT・財務分析
    Salt River Project - Strategy, SWOT and Corporate Finance Report Summary Salt River Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ono Pharmaceutical Co Ltd (4528):製薬・医療:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Zeta Petroleum Plc (ZTA):石油・ガス:M&Aディール及び事業提携情報
    Summary Zeta Petroleum Plc (Zeta) is an oil and gas exploration and production company. The company explores, develops and produces natural gas and crude oil. It owns and operates oil and gas assets such as Bobocu Gas Field, Suceava Concession, Jimbolia Oil Field, and Grivita Nord Oil Field. Zeta’s …
  • Ascopiave SpA (ASC):企業の財務・戦略的SWOT分析
    Ascopiave SpA (ASC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • GE Healthcare LLC-医療機器分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Tri Chemical Laboratories, Inc. (4369):企業の財務・戦略的SWOT分析
    Tri Chemical Laboratories, Inc. (4369) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Halozyme Therapeutics Inc (HALO):製薬・医療:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • POSCO ICT Company Ltd. (022100):企業の財務・戦略的SWOT分析
    POSCO ICT Company Ltd. (022100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆